Andrew J. Schwab - Director, 10%+ Owner at Enliven Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Issuer Symbol
ELVN on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew J. Schwab since 29 Jan 2025

Holdings reported by Andrew J. Schwab for Enliven Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 960,383 $14,535,397 $15.14 23 Feb 2023 Indirect
Stock Option (right to buy) 27,567 23 Feb 2023 Direct Common Stock

Transactions reported by Andrew J. Schwab for Enliven Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.